Equities

Ind Swift Ltd

INDSWFTLTD:NSI

Ind Swift Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)23.60
  • Today's Change-0.300 / -1.26%
  • Shares traded26.31k
  • 1 Year change+5.59%
  • Beta0.8133
Data delayed at least 15 minutes, as of Sep 20 2024 11:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments631133162
Total Receivables, Net1,5211,046906
Total Inventory641893696
Prepaid expenses------
Other current assets, total624661661
Total current assets3,4182,7342,424
Property, plant & equipment, net2,2482,3432,341
Goodwill, net------
Intangibles, net105119104
Long term investments7671,2921,434
Note receivable - long term------
Other long term assets7.294.0614
Total assets6,5456,4926,318
LIABILITIES
Accounts payable2,0192,3472,039
Accrued expenses7984123
Notes payable/short-term debt443,5493,655
Current portion long-term debt/capital leases1.472,347509
Other current liabilities, total1,0611,037850
Total current liabilities3,2049,3637,176
Total long term debt10,0954,0316,193
Total debt10,1409,92610,357
Deferred income tax----0
Minority interest------
Other liabilities, total154145152
Total liabilities13,45313,53913,521
SHAREHOLDERS EQUITY
Common stock108108108
Additional paid-in capital------
Retained earnings (accumulated deficit)(7017)(7155)(7312)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(6908)(7047)(7203)
Total liabilities & shareholders' equity6,5456,4926,318
Total common shares outstanding545454
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.